Chesapeake Corp

Chesapeake — Investor Presentation (February 2002)

33 slides from Chesapeake's investor presentation, Feb 14, 2002

  1. Slide 1: Investing in Chesapeake, February 11, 2002

    favesting en Che SADA Fepruury 11, 2002

  2. Slide 2: Forward-looking statements

    This presentation includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Changes in the following important factors, among others, could cause Chesapeake’s actual results to differ materially from those expres

  3. Slide 3: What is Chesapeake?

    What is Chesapeake? We are one of Europe's largest specialty packaging companies We are focused on the pharma and healthcare; international branded and multimedia & technology sectors We have superior manufacturing and service capabilities throughout Europe And a veteran management team

  4. Slide 4: Transformation of Chesapeake

    Briefly, a little information on the transformation of Chesapeake In 1997 we were --- Small player in a tough, capital intensive, kraft paper business --- A mid-sized player in C&I Tissue --- And, a much smaller player in corrugated containers and displays In short , we were capital intensive, cycli

  5. Slide 5: Our primary target markets are...

    Our primary target markets are... Why? Because these sectors offer faster growth (5%+ per year vs. 1-3% for commodity markets) and/or greater opportunity for differentiation and, therefore, margin enhancemen t. Our customers require sophisticated design and added value services Our target markets ha

  6. Slide 6: Value-added Defensive Markets

    Valu-added Defensive Markets Specialty Land Other Chemical 2% 4% 5% Pharma-Healthcare Food & Household Cosmetics 5% Technology 3% Confectionery Spirits 10% 9% Belgium Other 6% Ireland 5% 6% Germany 9% United States 6% France 9% 2001 Revenues $790 M United Kingdom 59%

  7. Slide 7: Now a little about our business segments

    Now a little about our 3 business segments starting with--.

  8. Slide 8: Paperboard packaging: 2001 revenues of $670 million

    With 2001 revenues of $670 million, we are a European market leader and Europe's leading pharma and healthcare packaging supplier Our paperboard packaging segment primarily produces folding cartons, labels and leaflets

  9. Slide 9: Significant manufacturing system throughout Europe

    We have a significant manufacturing system throughout Europe 43 plants in 7 countries This enables us to offer our customers better service in terms of delivery time and order size

  10. Slide 10: Largest in terms of revenues

    Largest in terms of revenues Not tons-that is the essence of the strategy higher $ higher margin target segments Now lets look at our competitors...

  11. Slide 11: Key competitors in pharmaceuticals and tobacco

    In pharmaceuticals, our key competitors are Alliances --groups of individual companies that have joined together---However, there is a reluctance to share information (both technical and managerial) with fellow partners -- so, in many ways they remain competitors. Also the status of these Alliances

  12. Slide 12: Now let's talk about our target markets

    Now let's talk about our target markets

  13. Slide 13: Text integrity and process controls for customers

    Text integrity and rigorous process controls are of paramount concern for our customers Our operations conform to ISO 9001/2 standards and the "Pharmaceutical Supplier Code of Practice" In a recent independent survey of pharma/healthcare companies, 91% of the companies surveyed would prefer to purch

  14. Slide 14: Pharmaceuticals — Text Integrity

    Pharmaceuticals — Text Integrity

  15. Slide 15: Premium branded goods: fine spirits and confectionery

    Our second target market is premium branded goods--which encompasses fine spirits and confectionery People around the world have more disposable income than ever before-and more consumers are able to buy these products In " image-oriented" markets, a large part of a products brand image is communica

  16. Slide 16: Product Positioning - Fine Spirits

    Product Positioning - Fine Spirits == 9%

  17. Slide 17: Range Extension - Confectionery

    Range Extension - Confectionery

  18. Slide 18: Tobacco packaging

    Another significant market for us is tobacco packaging-- We are one of Europe's largest suppliers of tobacco packaging, a position continuously enhanced through investment in the most advanced international manufacturing infrastructure Our in line gravure printing capabilities are among the best in

  19. Slide 19: Service Extension/Product Positioning

    Service Extension/Product Positioning cus eee | iit ‘T CUT cy sILK CU T

  20. Slide 20: Multimedia and technology markets growing faster

    Likewise the multimedia and technology markets are expected to grow at even faster rates These customers want innovative packaging and displays as brand awareness and retail presence become more important to their success. And they require just as much, if not more, specialization of packaging to he

  21. Slide 21: Penetrating the technology market, current customer list

    While we are just getting started in penetrating this market-..our current list already includes a few industry leaders This business is primarily run out of our Lexington, North Carolina location

  22. Slide 22: Our next business segment

    Our next business segment is -

  23. Slide 23: Plastic packaging segment

    Our plastic packaging segment serves the specialty chemical, beverages and pharmaceutical sectors We are a niche market leader in: - barrier containers for invasive fluids - PET soft drink containers in South Africa - and HDPE milk bottles in Ireland The division operates from 7 facilities located i

  24. Slide 24: Dominant positions in niche markets

    As we said earlier, we have dominant positions in niche markets. This means that, with the exception of the UK soft drinks sector, we have few major direct global competitors

  25. Slide 25: Third business segment: remaining legacy assets

    Our third business segment and only remaining legacy assets are...

  26. Slide 26: Valuable Land Assets

    ValuableLandAssets ## #=$= «© come Chesapeake’s land portfolio consists of approximately 20,000 acres Well-situated in Eastern Virginia — Washington, D.C. to Richmond to Williamsburg to Norfolk, VA Sold to developers and individual buyers for commercial and residential use Strategy — Maximize the va

  27. Slide 27: Financial Overview

  28. Slide 28: Pro Forma Historical Financial Data

    Pro Forma Historical Financial Data ~~ 2 Continuing Operations (Dollars in Millions) FY ENDED 1998 1999 2000 2001 Sales $ 770 $ 809 $ 801 $ 790 % Growth Constant Currency - 7.6% 9.0% 3.3% EBITDA* $ 105 $ 123 $ 131 $ 121 % Margin 13.7% 15.2% 16.4% 15.3% EBIT* $ 44 $ 55 $ 68 $ 61 % Margin 5.8% 6.8% 8.

  29. Slide 29: Pro Forma Historical Segment Results

    Continuing Operations (Dollars in Millions) Pro Forma Historical Segment Results 2000 2001 Sales Paperboard Packaging $ 678 $ 671 Plastic Packaging 102 98 Land Development Pl 21 Total $ 801 $ 790 EBITDA* Paperboard Packaging $ 113 $ 111 Plastic Packaging 18 13 Land Development 16 15 Corporate (16) (

  30. Slide 30: Capital Structure

    Capital Structure (8 millions) Net Debt Deferred Taxes Shareholders’ Equity Total Capital Net Debt/Capital 12/31/00 651 12/31/01 470 50 %

  31. Slide 31: Financial Outlook 2002

    Financial Outlook 2002 Continuing Operations Revenues $780 — 820 million Depreciation $45 - 50 million Capex $55 — 65 million EBITDA $125-135 million Net Income $1.60 - 1.80/share

  32. Slide 32: Top priority is operational excellence

    This year our top priority is operational excellence, strengthening our balance sheet, and reducing overhead Next year and beyond, our priorities include a North American folding carton platform and increased penetration in technology and multimedia However, we intend to apply discipline to our valu

  33. Slide 33: Investing in Chesapeake, February 11, 2002

    favesting en Che SADA Fepruury 11, 2002

Chesapeake — Investor Presentation (February 2002) on 6ix